Loading...

CTLLAB Clinitech Laboratory Ltd Other Special Situation Announcement

Clnt

CTLL

Clinitech Laboratory Ltd

(CTLLAB)

2025 Announcement

Reg 29(2 disclosure)

Regulatory disclosure

insider trading window

Insider trading disclosure

Regulatory disclosure

Reg 29(2 disclosure)

Regulatory disclosure under...

Regulatory disclosure under...

Subsidiary incorporation

Regulatory Compliance

Subsidiary incorporation

Subsidiary formation

Subsidiary Formation

Fund utilisation deviation

Subsidiary formation

Unaudited results

Board Meeting Notice

Board Meeting Notice

Centre Upgraded

Regulatory Exemption

Non-Applicability Notice

Regulation Compliance

Service Agreement

New Molecular Department

SEBI Compliance Update

Management Change

Resignation Announcement

Disclosure Exemption

No Fund Deviation

Non-Applicability Disclosure

SEBI Compliance Update

Regulatory Clarification

Investor Complaints Report

Compliance Certificate

New Partnership

Fund Utilization Report

RPT Exemption Notice

Investor Complaints Status

Regulatory Compliance

New Collection Center

New Branch Opening

External Links:

Data:

Clinitech Laboratory Ltd has confirmed that under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, its entire shareholding is in dematerialized form, and there were no requests for rematerialization for the quarter ending December 31, 2024.

AI Assistant

Clinitech Laboratory Ltd

2025

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.